SYMPTOMSDiabetic neuropathy affects all peripheral nerves: pain fibers,
motor neurons, autonomic nerves. It therefore necessarily can affect
all organs and systems since all are innervated. There are several
distinct syndromes based on the organ systems and members affected, but
these are by no means exclusive. A patient can have sensorimotor and
autonomic neuropathy or any other combination. Symptoms
vary depending on the nerve(s) affected and may include symptoms other
than those listed. Symptoms usually develop gradually over years.
Symptoms may include:
- Numbness and tingling of extremities
- Dysesthesia (decreased or loss of sensation to a body part)
- Diarrhea
- Erectile dysfunction
- Urinary incontinence (loss of bladder control)
- Impotence
- Facial, mouth and eyelid drooping
- Vision changes
- Dizziness
- Muscle weakness
- Difficulty swallowing
- Speech impairment
- Fasciculation (muscle contractions)
- Anorgasmia
- Burning or electric pain
TREATMENTDespite advances in the understanding of the metabolic causes of
neuropathy, treatments aimed at interrupting these pathological
processes have been limited. Thus, with the exception of tight glucose
control, treatments are for reducing pain and other symptoms.
Options for pain control include tricyclic antidepressants (TCAs), serotonin reuptake inhibitors (SSRIs) and antiepileptic drugs (AEDs). A systematic review concluded that "tricyclic antidepressants and traditional anticonvulsants are better for short term pain relief than newer generation anticonvulsants."[2] A combination of these medication (gabapentin + nortriptyline) may also be superior to a single agent.[3]
The only two drugs approved by the FDA for diabetic peripheral neuropathy are the antidepressant duloxetine and the anticonvulsant pregabalin.
Before trying a systemic medication, people with localized diabetic
periperal neuropathy might relieve their symptoms with lidocaine
patches.[1]
In addition to pharmacological treatment there are several other
modalities that help some cases. These have shown to reduce pain and
improve patient quality of life particularly for chronic neuropathic
pain: Interferential Stimulation; Acupuncture; Meditation; Cognitive
Therapy; and prescribed exercise.
Tricyclic antidepressants
TCAs include imipramine, amitriptyline, desipramine and nortriptyline.
These drugs are effective at decreasing painful symptoms but suffer
from multiple side effects that are dosage dependent. One notable side
effect is cardiac toxicity, which can lead to fatal arrhythmias. At low dosages used for neuropathy, toxicity
is rare, but if symptoms warrant higher doses, complications are more
common. Among the TCAs, amitriptyline is most widely used for this
condition, but desipramine and nortriptyline have fewer side effects.
Serotonin reuptake inhibitor
SSRIs include fluoxetine, paroxetine, sertraline and citalopram.
These agents have not been FDA approved to treat painful neuropathy
because they have been found to be no more efficacious than placebo in
several controlled trials. Side effects are rarely serious, and do not
cause any permanent disabilities. They cause sedation and weight gain,
which can worsen a diabetic's glycemic control. They can be used at
dosages that also relieve the symptoms of depression, a common concommitent of diabetic neuropathy.
The SSNRI duloxetine
(Cymbalta) is approved for diabetic neuropathy. By targeting both
serotonin and norepinephrine, it targets the painful symptoms of
diabetic neuropathy, and also treats depression if it exists. Typical
dosages are between 60 mg and 120 mg.
Antiepileptic drugs
AEDs, especially gabapentin and the related pregabalin,
are emerging as first line treatment for painful neuropathy. Gabapentin
compares favorably with amitriptyline in terms of efficacy, and is
clearly safer. Its main side effect is sedation, which does not
diminish over time and may in fact worsen. It needs to be taken three
times a day, and it sometimes causes weight gain, which can worsen
glycemic control in diabetics. Carbamazepine (Tegretol) is effective but not necessarily safe for diabetic neuropathy. Its first metabolite, oxcarbazepine, is both safe and effective in other neuropathic disorders, but has not been studied in diabetic neuropathy. Topiramate has not been studied in diabetic neuropathy, but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.
Other treatments
α-lipoic acid, an anti-oxidant that is a non-prescription dietary supplement has shown benefit in a randomized controlled trial that compared once-daily oral doses of 600 mg to 1800 mg compared to placebo, although nausea occurred in the higher doses.
Though not yet commercially available, C-peptide
has shown promising results in treatment of diabetic complications,
including neuropathies. Once thought to be a useless by-product of
insulin production, it helps to ameliorate and reverse the major
symptoms of diabetes.
In more recent years, Photo Energy Therapy devices are becoming more
widely used to treat neuropathic symptoms. Photo Energy Therapy devices
emit near infrared light (NIR Therapy) typically at a wavelength of
880 nm. This wavelength is believed to stimulate the release of Nitric Oxide, an Endothelium-derived relaxing factor
into the bloodstream, thus vasodilating the capilaries and venuoles in
the microcirculatory system. This increase in circulation has been
shown effective in various clinical studies to decrease pain in
diabetic and non-diabetic patients. Photo Energy Therapy devices seem to address the underlying problem of neuropathies, poor microcirculation, which leads to pain and numbness in the extremities
There has been experimental work testing the efficacy of a drug called sildenafil but this study described itself as an "isolated clinical report" and cited a need for further clinical investigation.
Tight glucose control
Treatment of early manifestations of sensorimotor polyneuropathy involves improving glycemic control.
Tight control of blood glucose can reverse the changes of diabetic
neuropathy, but only if the neuropathy and diabetes is recent in onset.
Conversely, painful symptoms of neuropathy in uncontrolled diabetics
tend to subside as the disease and numbness progress.
The mechanisms of diabetic neuropathy are poorly understood. At
present, treatment alleviates pain and can control some associated
symptoms, but the process is generally progressive.
As a complication, there is an increased risk of injury to the feet because of loss of sensation (see diabetic foot). Small infections can progress to ulceration and this may require amputation.
Metanx
Metanx® is a prescription
medical food for the dietary management of endothelial dysfunction in
patients with diabetic peripheral neuropathy.
How is Metanx® different than over-the-counter vitamins?
Traditional over-the-counter vitamins are synthetic forms of the
nutrients found in nature. This is the case for common B-vitamins such
as folic acid, vitamin B6 and vitamin B12.
Each of these must be converted into their natural, active forms before
they can actually be used by the body's cells for such vital functions
as DNA production, cell reproduction and homocysteine metabolism.
| B Vitamin |
Active Form |
| Folic acid |
 |
L-methylfolate |
| Vitamin B6 |
 |
Pyridoxal 5'-phosphate |
| Vitamin B12 |
 |
Methylcobalamin |
Metanx® is a prescription medical food and has a unique formulation providing the active forms of folate, vitamin B6 and vitamin B12
to manage the distinct nutritional requirements of diabetic neuropathy
patients who often experience numbness, tingling, and burning
sensations in their feet.
| Each Metanx® tablet contains: |
| L-methylfolate |
3mg |
| Pyridoxal 5'-phosphate |
35mg |
| Methylcobalamin |
2mg |
The bioefficacy of one Metanx® tablet can be compared to taking 19 folic acid tablets (1mg each) 2 B12 tablets (1mg each), and 2 B6 tablets (25mg each).
Did you know?
Up to 50% of individuals are unable to fully convert folic acid into the active form of folate, L-methylfolate.
Metanx® is available to nutritionally
manage endothelial dysfunction associated with numbness, tingling, and
burning sensations in diabetic neuropathy patients.
Serving communities of San Diego including
La Jolla, Del Mar, Poway, Santee, Rancho Bernardo, La Mesa
El Cajon, National City, Coranado, Solana Beach, Rancho Santa Fe,
Ramona, Escondido ,San Marcos, Vista, Oceanside, Carlsbad, Encinitas
Plantar Fasciitis/
Heel Spurs,
Bunions,
Hammertoes,
Ankle Fractures,
Foot Fractures,
Neuromas,
Flatfoot,
Achilles Tendon Disorders,
Orthotics,
Ingrown Toenails,
Fungal Nails,
High Arch,
Diabetic foot and Charcot foot,
Ankle Sprains and Strains,
Ankle Arthroscopy,
Bunionectomy & Bunion Surgery , Clubfoot, Work comp, workmans compensation